Most Recent Flipbooks

Expanding Noninvasive Prenatal Testing (NIPT) to Average Risk: MaterniT® 21 PLUS Performance in the Average Risk vs. High Risk Population

Abnormal ultrasound and increased yield of abnormal results with genome-wide cfDNA analysis

Expanding noninvasive prenatal testing (NIPT) for screening of unbalanced translocations

Genome wide detection of chromosomal gains and losses greater than 7Mb by cfDNA analysis

Clinical experience of trisomy 16 and 22, and microdeletion detection by noninvasive prenatal testing (NIPT)

Automated genomic interpretation of sub-chromosomal fetal copy number variation by sequencing circulating cell-free DNA from maternal plasma

Circulating cell-free DNA screening for fetal aneuploidy- the Newton-Wellesley Hospital Maternal Fetal Medicine experience

Identification of 22q11 microdeletions by noninvasive prenatal testing (NIPT) - the clinical experience

Karyotype-level noninvasive prenatal testing by sequencing of circulating cell-free DNA from maternal plasma

Noninvasive prenatal testing aids in detecting parental balanced translocation and highlights limitations of karyotyping

Rings and things- Noninvasive prenatal testing¹s unique view of the biology and embryology behind chromosomal ring formation and segregation